Literature DB >> 19244359

Altered hippocampal synaptic plasticity in the FMR1 gene family knockout mouse models.

Jing Zhang1, Lingfei Hou, Eric Klann, David L Nelson.   

Abstract

Fragile X syndrome (FXS) is the most common form of inherited mental retardation. The syndrome results from the absence of the fragile X mental retardation protein (FMRP), which is encoded by the fragile X mental retardation 1 (FMR1) gene. FMR1 and its two paralogs, fragile X-related genes 1 and 2 (FXR1 and -2), form the Fmr1 gene family. Here, we examined long-lasting synaptic plasticity in Fmr1 knockout, Fxr2 knockout, and Fmr1/Fxr2 double knockout mice. We found that metabotropic glutamate receptor-dependent long-term depression (mGluR-LTD) in the hippocampus was affected in Fmr1 knockout, Fxr2 knockout, and Fmr1/Fxr2 double knockout mice at young ages (4-6 wk old). In addition, Fmr1/Fxr2 double knockout mice showed significant deficiencies relative to either Fmr1 or Fxr2 knockout mice in baseline synaptic transmission and short-term presynaptic plasticity, suggesting FMRP and FXR2P may contribute in a cooperative manner to pathways regulating presynaptic plasticity. However, compared with wild-type littermates, late-phase long-term potentiation (L-LTP) was unaltered in all knockout mice at 4-6 mo of age. Interestingly, although Fmr1/Fxr2 double knockout mice exhibited a more robust enhancement in mGluR-LTD compared with that in Fmr1 knockout mice, Fxr2 knockout mice exhibited reduced mGluR-LTD. Furthermore, unlike Fmr1 knockout mice, mGluR-LTD in Fxr2 knockout mice required new protein synthesis, whereas mGluR-LTD in Fmr1/Fxr2 double knockout mice was partially dependent on protein synthesis. These results indicated that both FMRP and FXR2P function in synaptic plasticity and that they likely operate in related but independent pathways.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19244359      PMCID: PMC2681424          DOI: 10.1152/jn.90558.2008

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  46 in total

1.  The generation of a conditional Fmr1 knock out mouse model to study Fmrp function in vivo.

Authors:  E J Mientjes; I Nieuwenhuizen; L Kirkpatrick; T Zu; M Hoogeveen-Westerveld; L Severijnen; M Rifé; R Willemsen; D L Nelson; B A Oostra
Journal:  Neurobiol Dis       Date:  2005-10-26       Impact factor: 5.996

2.  Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits.

Authors:  T A Comery; J B Harris; P J Willems; B A Oostra; S A Irwin; I J Weiler; W T Greenough
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

3.  Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation.

Authors:  I J Weiler; S A Irwin; A Y Klintsova; C M Spencer; A D Brazelton; K Miyashiro; T A Comery; B Patel; J Eberwine; W T Greenough
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

4.  Different targets for the fragile X-related proteins revealed by their distinct nuclear localizations.

Authors:  F Tamanini; C Bontekoe; C E Bakker; L van Unen; B Anar; R Willemsen; M Yoshida; H Galjaard; B A Oostra; A T Hoogeveen
Journal:  Hum Mol Genet       Date:  1999-05       Impact factor: 6.150

5.  Fear conditioning induces a lasting potentiation of synaptic currents in vitro.

Authors:  M G McKernan; P Shinnick-Gallagher
Journal:  Nature       Date:  1997-12-11       Impact factor: 49.962

6.  Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP.

Authors:  Q J Yan; M Rammal; M Tranfaglia; R P Bauchwitz
Journal:  Neuropharmacology       Date:  2005-07-27       Impact factor: 5.250

7.  Deletion of FMR1 in Purkinje cells enhances parallel fiber LTD, enlarges spines, and attenuates cerebellar eyelid conditioning in Fragile X syndrome.

Authors:  S K E Koekkoek; K Yamaguchi; B A Milojkovic; B R Dortland; T J H Ruigrok; R Maex; W De Graaf; A E Smit; F VanderWerf; C E Bakker; R Willemsen; T Ikeda; S Kakizawa; K Onodera; D L Nelson; E Mientjes; M Joosten; E De Schutter; B A Oostra; M Ito; C I De Zeeuw
Journal:  Neuron       Date:  2005-08-04       Impact factor: 17.173

8.  The fragile X mental retardation protein is associated with poly(A)+ mRNA in actively translating polyribosomes.

Authors:  F Corbin; M Bouillon; A Fortin; S Morin; F Rousseau; E W Khandjian
Journal:  Hum Mol Genet       Date:  1997-09       Impact factor: 6.150

9.  Pharmacological rescue of synaptic plasticity, courtship behavior, and mushroom body defects in a Drosophila model of fragile X syndrome.

Authors:  Sean M J McBride; Catherine H Choi; Yan Wang; David Liebelt; Evan Braunstein; David Ferreiro; Amita Sehgal; Kathleen K Siwicki; Thomas C Dockendorff; Hanh T Nguyen; Thomas V McDonald; Thomas A Jongens
Journal:  Neuron       Date:  2005-03-03       Impact factor: 17.173

10.  FMRP associates with polyribosomes as an mRNP, and the I304N mutation of severe fragile X syndrome abolishes this association.

Authors:  Y Feng; D Absher; D E Eberhart; V Brown; H E Malter; S T Warren
Journal:  Mol Cell       Date:  1997-12       Impact factor: 17.970

View more
  61 in total

1.  Fragile X mental retardation protein: regulator of specific mRNAs or master regulator of global translation?

Authors:  Denise Cook; Scott A Cameron; Emma V Jones
Journal:  J Neurosci       Date:  2010-05-26       Impact factor: 6.167

2.  The GABA(A) receptor agonist THIP ameliorates specific behavioral deficits in the mouse model of fragile X syndrome.

Authors:  Jose Luis Olmos-Serrano; Joshua G Corbin; Mark P Burns
Journal:  Dev Neurosci       Date:  2011-11-08       Impact factor: 2.984

3.  Pharmacological rescue of cortical synaptic and network potentiation in a mouse model for fragile X syndrome.

Authors:  Tao Chen; Jing-Shan Lu; Qian Song; Ming-Gang Liu; Kohei Koga; Giannina Descalzi; Yun-Qing Li; Min Zhuo
Journal:  Neuropsychopharmacology       Date:  2014-02-20       Impact factor: 7.853

Review 4.  The translation of translational control by FMRP: therapeutic targets for FXS.

Authors:  Jennifer C Darnell; Eric Klann
Journal:  Nat Neurosci       Date:  2013-04-14       Impact factor: 24.884

Review 5.  Fragile X Syndrome and Alzheimer's Disease: Another story about APP and beta-amyloid.

Authors:  J S Malter; B C Ray; P R Westmark; C J Westmark
Journal:  Curr Alzheimer Res       Date:  2010-05       Impact factor: 3.498

6.  Homeostatic responses fail to correct defective amygdala inhibitory circuit maturation in fragile X syndrome.

Authors:  Rebecca L Vislay; Brandon S Martin; Jose Luis Olmos-Serrano; Sebila Kratovac; David L Nelson; Joshua G Corbin; Molly M Huntsman
Journal:  J Neurosci       Date:  2013-04-24       Impact factor: 6.167

7.  Activity-dependent modulation of neural circuit synaptic connectivity.

Authors:  Charles R Tessier; Kendal Broadie
Journal:  Front Mol Neurosci       Date:  2009-07-30       Impact factor: 5.639

8.  Discrimination of common and unique RNA-binding activities among Fragile X mental retardation protein paralogs.

Authors:  Jennifer C Darnell; Claire E Fraser; Olga Mostovetsky; Robert B Darnell
Journal:  Hum Mol Genet       Date:  2009-06-01       Impact factor: 6.150

9.  Signals, synapses, and synthesis: how new proteins control plasticity.

Authors:  R Suzanne Zukin; Joel D Richter; Claudia Bagni
Journal:  Front Neural Circuits       Date:  2009-10-07       Impact factor: 3.492

10.  Presynaptic translation: stepping out of the postsynaptic shadow.

Authors:  Michael R Akins; Hanna E Berk-Rauch; Justin R Fallon
Journal:  Front Neural Circuits       Date:  2009-11-04       Impact factor: 3.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.